From: Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
Indicators | Baseline | 3 months | 6 months | 12 months | xʹ2 | Pʹ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Total | x2 | P | Total | x2 | P | Total | x2 | P | |||
TSH (mIU/l) | 0.005 (0.005, 0.010) | 6.650 (0.008, 61.65) | − 1.602 | < 0.001 | 3.800 (0.083, 22.323) | − 0.079 | 0.425 | 4.000 (0.760, 13.620) | − 0.022 | 0.824 | 404.89 | < 0.001 |
FT3 (pmol/l) | 24.95 (14.60, 35.80) | 2.96 (1.45, 5.43) | 2.257 | < 0.001 | 4.14 (3.27, 5.42) | − 0.543 | < 0.001 | 4.21 (3.66, 4.90) | − 0.030 | 0.758 | 600.63 | < 0.001 |
FT4 (pmol/l) | 60.29 (38.55, 100.00) | 7.42 (3.07, 19.21) | 2.178 | < 0.001 | 16.76 (11.58, 21.26) | 0.546 | < 0.001 | 16.91 (13.61, 20.43) | − 0.057 | 0.557 | 551.69 | < 0.001 |
TRAb (IU/ml) | 14.32 (6.99, 32.35) | 37.84 (16.53, 40.00) | − 0.942 | 0.008 | 25.72 (11.75, 40.00) | − 0.173 | 0.629 | 17.52 (5.38, 32.83) | − 1.327 | < 0.001 | 25.055 | < 0.001 |
TPOAb (IU/ml) | 295.5 (83.0, 563.8) | 600.0 (321.8, 600.0) | − 1.646 | < 0.001 | 537.6 (278.7, 600.0) | − 0.061 | 0.831 | 333.6 (128.9, 557.5) | − 1.110 | < 0.001 | 59.049 | < 0.001 |
TgAb (IU/l) | 212.3 (39.39, 620.3) | 405.1 (120.9, 660.0) | − 0.939 | 0.001 | 318.4 (104.7, 650.5) | − 0.415 | 0.146 | 149.6 (31.7, 499.5) | − 0.622 | 0.029 | 17.692 | 0.001 |
Median heart rate (bpm) | 93.23 ± 16.53 | 73.08 ± 12.64 | 1.438 | < 0.001 | 74.51 ± 13.70 | − 0.042 | 0.911 | 75.30 ± 12.44 | − 0.188 | 0.615 | 27.106 | < 0.001 |